Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Aug 18, 2016
EDEN PRAIRIE, Minn., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and Chairman of the Board, John Erb, is scheduled to present at the 2016 investMNt Conference in Minneapolis, MN on August 24th at 11:45 AM CT. To access t...

Read More

Posted on Aug 16, 2016
EDEN PRAIRIE, Minn., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today the appointment of Megan Brandt to the position of Vice President of Regulatory Affairs and Quality Assurance. In this capacity, Ms. Brandt will facilitate and manage quality and regulatory aff...

Read More

Posted on Aug 9, 2016
EDEN PRAIRIE, Minn., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results for the second quarter ended June 30, 2016. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update ...

Read More

Events & Presentations

Posted on Aug 24, 2016 at 11:45 AM CT